Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
US Department of Justice
Accenture
Cantor Fitzgerald
Express Scripts
QuintilesIMS
Deloitte
Medtronic
Argus Health

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020740

« Back to Dashboard

NDA 020740 describes BAYCOL, which is a drug marketed by Bayer Pharms and is included in one NDA. Additional details are available on the BAYCOL profile page.

The generic ingredient in BAYCOL is cerivastatin sodium. Additional details are available on the cerivastatin sodium profile page.
Summary for 020740
Tradename:BAYCOL
Applicant:Bayer Pharms
Ingredient:cerivastatin sodium
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.05MG
Approval Date:Jun 26, 1997TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.1MG
Approval Date:Jun 26, 1997TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.2MG
Approval Date:Jun 26, 1997TE:RLD:No

Expired US Patents for NDA 020740

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-005 May 24, 1999 ➤ Sign Up ➤ Sign Up
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-004 Jun 26, 1997 ➤ Sign Up ➤ Sign Up
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-002 Jun 26, 1997 ➤ Sign Up ➤ Sign Up
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-002 Jun 26, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Daiichi Sankyo
Merck
Medtronic
Express Scripts
UBS
Accenture
Healthtrust
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.